Comparative safety and effectiveness of warfarin, dabigatran, and rivaroxaban among Japanese patients with non-valvular atrial fibrillation (NVAF) and concomitant coronary artery disease (CAD) (1160.0308) First published 31/05/2021 Last updated 01/02/2023 EU PAS number:EUPAS41345 Study Finalised